Norneda - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 42,418 | 35,130 | 39,550 | 43,681 | 33,216 | 31,761 | 42,195 | 40,915 |
| Profit before tax | - | - | - | - | - | - | 19,715 | - |
| Net profit | 4,621 | -12,618 | 7,836 | 5,614 | -5,021 | -7,421 | 19,261 | -152 |
| Equity | 42,318 | 29,700 | 37,536 | 43,149 | 38,128 | 30,706 | 49,968 | 49,816 |
| Liabilities | 3,562 | 3,208 | 5,079 | 2,220 | 1,015 | 1,446 | 3,084 | 3,453 |
| Non-current assets | 30,225 | 22,818 | 16,823 | 10,785 | 4,746 | 167 | 12 | 12 |
| Current assets | 15,655 | 10,090 | 25,792 | 34,584 | 34,397 | 31,985 | 53,040 | 53,257 |
| Total assets | 45,880 | 32,908 | 42,615 | 45,369 | 39,143 | 32,152 | 53,052 | 53,269 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,067 | 1,094 | 2,261 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +6.5% | -17.2% | +12.6% | +10.4% | -24.0% | -4.4% | +32.9% | -3.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 10.1% | -38.3% | 18.4% | 12.4% | -12.8% | -23.1% | 36.3% | -0.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 10.9% | -42.5% | 20.9% | 13.0% | -13.2% | -24.2% | 38.5% | -0.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 10.9% | -35.9% | 19.8% | 12.9% | -15.1% | -23.4% | 45.6% | -0.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | 46.7% | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 10,605 | 8,603 | 9,888 | 12,480 | 11,072 | 10,587 | 14,065 | 13,638 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Norneda - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-03-07 | 2023-03-09 | 27.57 |
| 2023-02-17 | 2023-03-06 | 8.34 |
Norneda - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Norneda, UAB (code 125358981) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €40.9K, down 3.0% year on year, and posted a net loss of €152, which corresponds to a profit margin of -0.4%. This followed a much stronger 2024, when revenue reached €42.2K and net profit was €19.3K, after a loss of €7.4K in 2023 on revenue of €31.8K. Over the 2-year period, revenue increased by 28.8%, although profitability weakened in 2025 after the prior-year recovery. At the end of 2025, total assets stood at €53.3K, equity at €49.8K, and liabilities at €3.5K, indicating a strong equity base and low leverage. The equity ratio was 93.5%, debt-to-equity was 0.07, and asset turnover was 0.77x. Return on equity and return on assets were both -0.3%. Revenue per employee was €13.6K, while profit per employee was -€51.